SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-17-000047
Filing Date
2017-02-17
Accepted
2017-02-17 17:44:54
Documents
2
Period of Report
2017-02-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4035
2 POWER OF ATTORNEY poacola.htm EX-24 3499
  Complete submission text file 0001192482-17-000047.txt   9092
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Issuer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 435 DEVON PARK BUILDING 800 WAYNE PA 19087-1945
Business Address
COLA MICHAEL F (Reporting) CIK: 0001188940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35112 | Film No.: 17622594